Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

IOncology

Home » IOncology » Page 25
Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer

Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer

Posted by By Ren Jiamo 2025.07.01
Read More
Early research, clinical practice and thinking of innovative NK cell therapy

Early research, clinical practice and thinking of innovative NK cell therapy

Posted by By Mourabit Halima 2025.07.01
Read More
Clinical and Translational Research on Gastric Cancer Based on Molecular Typing

Clinical and Translational Research on Gastric Cancer Based on Molecular Typing

Posted by By Peng Longmei 2025.07.01
Read More
Research Progress of Artificial Intelligence in the Field of Digestive System Tumors

Research Progress of Artificial Intelligence in the Field of Digestive System Tumors

Posted by By Mourabit Halima 2025.07.01
Read More
Enhancing CAR T Therapy toTarget Solid Tumors

Enhancing CAR T Therapy toTarget Solid Tumors

Posted by By El Bachir MOURABIT 2025.07.01
Read More
From Pursuing Surgical Techniques to Changing Treatment Models: Twenty Years of Exploration Leading to Standardized Diagnosis and Treatment of Esophageal Cancer

From Pursuing Surgical Techniques to Changing Treatment Models: Twenty Years of Exploration Leading to Standardized Diagnosis and Treatment of Esophageal Cancer

Posted by By Mourabit Halima 2025.06.30
Read More
Future Directions of Targeted Therapy for Colorectal Cancer from Perspective of New Drug Development

Future Directions of Targeted Therapy for Colorectal Cancer from Perspective of New Drug Development

Posted by By Mourabit Halima 2025.06.30
Read More
ASCO International Perspectives | Professor Thomas Powles: Rapid Advances in Targeted and Immunotherapy – EV and Durvalumab-Based Regimens Improve Survival in Urothelial Carcinoma Patients

ASCO International Perspectives | Professor Thomas Powles: Rapid Advances in Targeted and Immunotherapy – EV and Durvalumab-Based Regimens Improve Survival in Urothelial Carcinoma Patients

Posted by By Artie Zou (Lili Zou) 2025.06.30
Read More
PI Panel: Integrating Eastern and Western Perspectives — Future Innovations in Esophageal Cancer Management

PI Panel: Integrating Eastern and Western Perspectives — Future Innovations in Esophageal Cancer Management

Posted by By Mourabit Halima 2025.06.30
Read More
 Thomas Fitzpatrick at APACC 2025 | Community-Driven Models for DoxyPep Access

 Thomas Fitzpatrick at APACC 2025 | Community-Driven Models for DoxyPep Access

Posted by By Mourabit Halima 2025.06.27
Read More

Posts pagination

Previous page 1 … 20
Recent Posts
  • Professor Yige Bao: From “New Leaves Spur the Old” to “One Mountain Opens, Another Blocks the Way” —Reflections and Challenges in Post-Neoadjuvant Management of MIBC
  • ESMO Hot Topic Focus | Professor Richard S. Finn: Immunotherapy-Based Combinations Turn “Stone into Gold” — The TALENTOP Study Reshapes the Treatment Landscape of Advanced HCC
  • ESMO International Perspective | Professor Maria Reig: Large International Multicenter Evidence Supports the Inclusion of EBRT in the BCLC Staging and Treatment Algorithm
  • ESMO International Perspective | 42-Month Long-Term Follow-Up with Median OS of 22.8 Months: Professor Manon Allaire Interprets the Outstanding Real-World Performance of the “T+A” Regimen
  • ESMO International Perspective | Global Lung Cancer Experts Discuss the OptiTROP-Lung04 Study: Sacituzumab Tirumotecan Breaks Through Post-TKI Resistance
Recent Comments
    Archives
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top